Cardiol Therapeutics(DE:CT9)
€0.96+0.06 (+14.29%)
DE:CT9
Cardiol Therapeutics ownership
€0.96
At close:+0.06 (+14.29%)
Cardiol Therapeutics (CT9) Ownership - Who Owns Cardiol Therapeutics?
0 Followers
Cardiol Therapeutics (CT9) Ownership Overview
- 1.13% Insiders
- 0.02% Mutual Funds
- 6.79% Other Institutional Investors
- 0.08% ETFs
- 91.98% Public Companies and Individual Investors
The ownership structure of Cardiol Therapeutics (DE:CT9) stock is a mix of institutional, retail, and individual investors. Approximately 6.89% of the company’s stock is owned by Institutional Investors, 1.13% is owned by Insiders, and 91.98% is owned by Public Companies and Individual Investors.
The ownership structure of Cardiol Therapeutics (DE:CT9) stock is a mix of institutional, retail, and individual investors. Approximately 6.89% of the company’s stock is owned by Institutional Investors, 1.13% is owned by Insiders, and 91.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Andrew Warwick Hamer | 739,947 | Insider | 0.61% | 788,044 |
| Guillermo Torre | 334,309 | Insider | 0.28% | 356,039 |
| Jennifer Chao | 146,667 | Insider | 0.12% | 156,200 |
| Teri Loxam | 146,667 | Insider | 0.12% | 156,200 |
| State Street | 101,498 | Institution | 0.08% | 108,095 |
| Fidelity Concord Street Trust | 18,467 | Institution | 0.02% | 19,667 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 18,467 | Institution | 0.02% | 19,667 |
FAQ
Who Owns Cardiol Therapeutics (DE:CT9)?
According to the latest TipRanks data, approximately 6.89% of the company's stock is held by institutional investors, 1.13% is held by insiders, and 91.98% is held by public companies and individual investors.
What percentage of Cardiol Therapeutics (DE:CT9) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.89% of Cardiol Therapeutics (DE:CT9) stock is held by institutional investors: 0.02% by mutual funds, 0.08% by ETFs and 6.79% by other institutional investors.
What percentage of Cardiol Therapeutics (DE:CT9) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.98% of Cardiol Therapeutics (DE:CT9) stock is held by public companies and individual investors.
Who owns the most shares of Cardiol Therapeutics (DE:CT9)?
Andrew Warwick Hamer owns the most shares of Cardiol Therapeutics (DE:CT9).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
